Biotechnology regulation at the crossroads

The biotechnology industry was jubilant when its calls for a relaxation of regulations on the contained use and deliberate release of genetically modified organisms (GMOs) were endorsed in October by a report from the House of Lords Select Committee on Science and Technology.1 The report's outspoken recommendations in favour of cutting red tape in order to unleash the industry's promised wealth-creating potential have perplexed regulators who say they were already doing most of what it recommends. And some scientists are unhappy at the way in which the Committee dismissed as "conjectural" the concerns about GMOs' potential to damage the environment voiced by the Royal Commission on Environmental Pollution (RCEP) four years ago.

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here


Call: 020 8267 8120

Take a 30-day trial

  • Join ENDS Report now and pay nothing for your first 30-days.



Prices on request

  • Full access to for 12 months
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits

Need to activate your subscription?
Already a subscriber
If you haven't already, activate your subscription here>>
Company Domain Access
If your company or university has a corporate subscription simply register your email address here to gain access